Abstract | PURPOSE: PATIENTS AND METHODS: The clinical, angiographic and optical coherence tomography (OCT) results of patients with long-standing chronic central serous chorioretinopathy (CCSC) treated with LFV- PDT in the Lyon Centre Rabelais between 2002 and 2008 were retrospectively analyzed. A comprehensive check-up (macular syndrome signs, ETDRS best-corrected visual acuity [BCVA], biomicroscopy, fluorescein [FA] and indocyanine green [ICGA] angiographies, OCT scans) was performed before LFV- PDT treatment and 3 months later. Patients were then followed regularly and retreated in case of recurrence. The LFV- PDT treatment, with a fluence of 25 J/cm(2) at an irradiance of 300 mW, was guided by ICGA. RESULTS: Forty-one eyes of 34 patients (27 males; mean age: 53 years) were included, of which 18 eyes had already been treated with laser photocoagulation. Several leaking points were visible on FA in most of the cases (n=38), mainly in the macula (35 cases). Before treatment, metamorphopsia was noted in 51% of the cases, intraretinal edema (IRE) was present on OCT scans in 71%, serous retinal detachment (SRD) in 85%, and pigment epithelial detachment (PED) in 10%. Thirty-nine eyes had only one treatment session and one eye was retreated once. At 3 months after LFV- PDT, IRE was present in 15% of the cases, SRD in 12%, and PED in 2%. At the end of the 20-month follow-up, IRE was present in 14% of the cases, SRD in 15%, and PED in 0%. Macular atrophy was observed on OCT in most of the cases at the end of the follow-up (mean central thickness, 144.5 μm). Compared to the initial BCVA, at 3 months after LFV- PDT, BCVA decreased in 22% of the cases, stabilized in 39%, and increased in 39%, while at the end of the follow-up, BCVA decreased in 12% of the cases, stabilized in 17%, and increased in 71%. No complication was observed. DISCUSSION: LFV- PDT treatment for patients with long-standing chronic central serous chorioretinopathy results in anatomical and functional improvement (sustained disappearance of the exudative phenomenon in most cases and increased BCVA in more than two-thirds of the cases). The macular atrophy observed may be due to the treatment or the natural course of the disease.
|
Authors | P-L Cornut, M Quaranta-El Maftouhi, M Mauget-Faÿsse |
Journal | Journal francais d'ophtalmologie
(J Fr Ophtalmol)
Vol. 35
Issue 2
Pg. 82-7
(Feb 2012)
ISSN: 1773-0597 [Electronic] France |
Vernacular Title | Intérêt de la photothérapie dynamique dans les choriorétinopathies séreuses centrales chroniques et les épithéliopathies rétiniennes diffuses exsudatives. |
PMID | 21889817
(Publication Type: Evaluation Study, Journal Article)
|
Copyright | Copyright © 2011 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Photosensitizing Agents
- Porphyrins
- Verteporfin
|
Topics |
- Adult
- Aged
- Central Serous Chorioretinopathy
(drug therapy)
- Female
- Humans
- Male
- Middle Aged
- Photochemotherapy
(methods)
- Photosensitizing Agents
(administration & dosage, adverse effects, therapeutic use)
- Porphyrins
(administration & dosage, adverse effects, therapeutic use)
- Retinal Diseases
(drug therapy, pathology)
- Retinal Pigment Epithelium
(pathology)
- Retrospective Studies
- Treatment Outcome
- Verteporfin
- Visual Acuity
(drug effects, physiology)
|